Rigshospitalet is the largest hospital in Denmark and the most highly specialised hospital in the country. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,118 beds in Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen.

During the past decade, Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen" #1 sponsor was "Rigshospitalet, Denmark" with 12 trials, followed by "JKastrup" with 4 trials sponsored, "Thomas Engstrom" with 2 trials sponsored, "Klaus Fuglsang Kofoed" with 1 trials sponsored and "Zealand Pharma" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen" #1 collaborator was "Herlev Hospital" with 2 trials as a collaborator, "University Hospital, Gentofte, Copenhagen" with 2 trials as a collaborator, "Amager Hospital" with 1 trials as a collaborator, "Bispebjerg Hospital" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen" are "Coronary Artery Disease" (4 trials), "Heart Failure" (4 trials), "Acute Myocardial Infarction" (2 trials), "Cardiovascular Diseases" (2 trials) and "ST Elevation Myocardial Infarction" (2 trials). Many other conditions were trialed in "Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen" in a lesser frequency.

Most popular intervention types in "Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen" are "Biological" (5 trials), "Drug" (5 trials), "Procedure" (5 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Saline" (2 trials), "Allogeneic adipose derived stem cells (CSCC_ASC)" (1 trials), "Allogeneic adipose-derived stromal cells (CSCC_ASC)" (1 trials) and "CSCC_ASC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen" are 19 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen, 6 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".